Suzanne Christina Bodor-Billings, MD
Internal Medicine · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 40 years
- University of Texas Medical School at Houston, 1986
Offices
1 location · My Health Medical Group Inc · 10 clinicians in this group
Looking this up.
Hospitals listed: 053137 · 057004 · 057517 · 059551 · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bodor-Billings’s office at (510) 848-7977 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A71432 · Current
Licensed to practise in California · since 2000 · expires 2027-10-31 · University of Texas Medical School at Houston.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$89,214
Medicare paid this office $89,214 for 255 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 138 | $27,325 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 120 | $18,670 | $156 |
| Short return visit (20+ min) | 124 | $15,468 | $78 |
| Transitional care management services for problem of high complexity | 23 | $6,511 | $271 |
| Long return visit (40+ min) | 16 | $3,220 | $161 |
See all 11 services
| Return visit (30+ min) | 138 | $27,325 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 120 | $18,670 | $156 |
| Short return visit (20+ min) | 124 | $15,468 | $78 |
| Transitional care management services for problem of high complexity | 23 | $6,511 | $271 |
| Long return visit (40+ min) | 16 | $3,220 | $161 |
| Transitional care management services for problem of at least moderate complexity | 14 | $2,813 | $201 |
| Annual alcohol misuse screening, 5 to 15 minutes | 66 | $1,586 | $24 |
| Annual depression screening, 5 to 15 minutes | 50 | $1,201 | $24 |
| Influenza vaccine split virus, preservative free | 12 | $982 | $82 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $839 | $52 |
| Administration of influenza virus vaccine | 17 | $658 | $39 |
Who their Medicare patients are
255 Original Medicare patients in 2024. Average age 79 · Under 65 0% · 85 and older 23% · Women 70% · Health risk score 0.91. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 51% · Cancer 19% · Depression 17% · Chronic kidney disease 12% · Diabetes 11% · Atrial fibrillation 11% · Stroke 11% · Coronary heart disease 8% · Dementia 6% · Heart failure 5% · COPD 5%.
The office billed $256,947, Medicare allowed $110,600 and paid $89,214; for 872 services of 34 kinds; $5,027 of it was for drugs given in the office and $84,187 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 255 | 872 | 79 | 0.91 | $256,947 | $89,214 |
| 2023 | 300 | 1,091 | 79 | 0.88 | $262,923 | $91,791 |
| 2022 | 279 | 728 | 78 | 0.87 | $135,751 | $67,416 |
| 2021 | 251 | 723 | 78 | 0.86 | $114,130 | $67,004 |
| 2020 | 223 | 736 | 77 | 0.96 | $94,768 | $48,226 |
| 2019 | 274 | 937 | 77 | 0.94 | $125,282 | $68,909 |
| 2018 | 229 | 723 | 77 | 0.96 | $105,306 | $58,956 |
| 2017 | 209 | 696 | 77 | 0.84 | $100,918 | $53,973 |
| 2016 | 214 | 544 | 77 | 1.00 | $86,442 | $41,706 |
| 2015 | 199 | 518 | 76 | 0.90 | $76,887 | $40,563 |
| 2014 | 178 | 560 | 76 | 0.97 | $74,571 | $38,272 |
| 2013 | 166 | 528 | 75 | 1.02 | $65,331 | $32,596 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 139 | $23,683 | $100 |
| Short return visit (20+ min) | 180 | $22,459 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 129 | $17,953 | $139 |
| Long return visit (40+ min) | 27 | $4,513 | $133 |
| Transitional care management services for problem of high complexity | 13 | $3,365 | $240 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 39 | $2,957 | $76 |
| Short return visit | 38 | $1,498 | $37 |
| Administration of influenza virus vaccine | 40 | $1,321 | $33 |
| Annual depression screening, 5 to 15 minutes | 39 | $818 | $21 |
| Annual alcohol misuse screening, 5 to 15 minutes | 37 | $776 | $21 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $734 | $46 |
| Administration of pneumococcal vaccine | 12 | $396 | $33 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $164 | $11 |
2022: 10 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 139 | $21,388 | $154 |
| Return visit (30+ min) | 90 | $13,929 | $103 |
| Short return visit (20+ min) | 113 | $12,180 | $68 |
| Long return visit (40+ min) | 25 | $3,633 | $135 |
| New patient visit (60+ min) | 14 | $2,631 | $188 |
| Short return visit | 61 | $2,579 | $33 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 36 | $2,521 | $70 |
| Administration of influenza virus vaccine | 36 | $1,299 | $36 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18 | $962 | $51 |
| Administration of pneumococcal vaccine | 17 | $616 | $36 |
2021: 7 services
| Return visit (30+ min) | 97 | $14,826 | $108 |
| Short return visit (20+ min) | 119 | $14,758 | $78 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 84 | $13,169 | $157 |
| Long return visit (40+ min) | 66 | $10,764 | $145 |
| Short return visit | 48 | $3,238 | $52 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 43 | $2,856 | $66 |
| Administration of influenza virus vaccine | 43 | $900 | $21 |
2020: 8 services
| Short return visit (20+ min) | 139 | $13,928 | $61 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 95 | $13,125 | $138 |
| Return visit (30+ min) | 95 | $11,395 | $81 |
| Annual alcohol misuse screening, 5 to 15 minutes | 91 | $2,028 | $22 |
| Influenza vaccine, inactivated | 20 | $1,191 | $60 |
| Administration of influenza virus vaccine | 25 | $515 | $21 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 28 | $395 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $264 | $14 |
2019: 12 services
| Short return visit (20+ min) | 180 | $19,247 | $63 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 130 | $17,954 | $138 |
| Return visit (30+ min) | 108 | $13,983 | $88 |
| New patient visit (60+ min) | 33 | $5,827 | $177 |
| Pneumococcal vaccine, 13-valent | 13 | $2,612 | $201 |
| Annual alcohol misuse screening, 5 to 15 minutes | 99 | $2,191 | $22 |
| Pneumococcal vaccine, 23-valent | 13 | $1,395 | $107 |
| Influenza vaccine, inactivated | 20 | $1,167 | $58 |
| Administration of influenza virus vaccine | 26 | $525 | $20 |
| Administration of pneumococcal vaccine | 26 | $525 | $20 |
| Annual depression screening, 5 to 15 minutes | 17 | $376 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $311 | $16 |
2018: 9 services
| Return visit (30+ min) | 102 | $16,475 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 110 | $15,214 | $138 |
| Short return visit (20+ min) | 133 | $13,259 | $58 |
| New patient visit (60+ min) | 27 | $4,673 | $173 |
| Pneumococcal vaccine, 13-valent | 18 | $3,557 | $198 |
| Administration of influenza virus vaccine | 30 | $759 | $25 |
| Administration of pneumococcal vaccine | 27 | $708 | $25 |
| Influenza vaccine, inactivated | 17 | $620 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $309 | $15 |
2017: 9 services
| Return visit (30+ min) | 90 | $14,697 | $94 |
| Short return visit (20+ min) | 136 | $14,393 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 87 | $11,683 | $134 |
| Pneumococcal vaccine, 13-valent | 29 | $5,062 | $175 |
| New patient visit (60+ min) | 17 | $2,811 | $165 |
| Administration of influenza virus vaccine | 32 | $970 | $29 |
| Administration of pneumococcal vaccine | 32 | $941 | $29 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 32 | $569 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $226 | $13 |
2016: 8 services
| Short return visit (20+ min) | 130 | $13,361 | $57 |
| Return visit (30+ min) | 71 | $10,022 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 70 | $9,190 | $131 |
| Pneumococcal vaccine, 13-valent | 22 | $3,892 | $177 |
| New patient visit (60+ min) | 13 | $2,361 | $182 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $777 | $41 |
| Administration of pneumococcal vaccine | 22 | $647 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $140 | $13 |
2015: 4 services
| Short return visit (20+ min) | 142 | $18,210 | $61 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 66 | $8,708 | $132 |
| New patient visit (60+ min) | 34 | $5,911 | $174 |
| Return visit (30+ min) | 49 | $5,698 | $92 |
2014: 8 services
| Short return visit (20+ min) | 133 | $18,054 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $6,564 | $129 |
| Return visit (30+ min) | 44 | $5,896 | $95 |
| New patient visit (60+ min) | 25 | $3,944 | $158 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $1,374 | $44 |
| Administration of influenza virus vaccine | 22 | $647 | $29 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 22 | $332 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $244 | $14 |
2013: 8 services
| Short return visit (20+ min) | 112 | $14,797 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 54 | $6,865 | $127 |
| Return visit (30+ min) | 39 | $4,637 | $86 |
| New patient visit (60+ min) | 13 | $2,090 | $161 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $1,013 | $39 |
| Administration of influenza virus vaccine | 23 | $676 | $29 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 23 | $272 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $235 | $15 |
Drugs they prescribed that Part D paid
$178,486
Pharmacies billed $178,486 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (21 of 2,769) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
2,540 generic and 229 brand-name prescriptions · $178,486 in drug cost · 76 antibiotic prescriptions to 51 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 22 | $37,574 | $1,708 |
| Farxiga | 13 | $11,709 | $901 |
| Premarin | 14 | $6,757 | $483 |
| Symbicort | 11 | $4,811 | $437 |
| Levothyroxine | 168 | $2,742 | $16 |
See all 63 drugs
| Eliquis | 22 | $37,574 | $1,708 |
| Farxiga | 13 | $11,709 | $901 |
| Premarin | 14 | $6,757 | $483 |
| Symbicort | 11 | $4,811 | $437 |
| Levothyroxine | 168 | $2,742 | $16 |
| Gabapentin | 67 | $2,172 | $32 |
| Atorvastatin | 215 | $2,045 | $10 |
| Estradiol | 26 | $1,849 | $71 |
| Losartan | 112 | $1,736 | $15 |
| Omeprazole | 37 | $1,549 | $42 |
| Mirtazapine | 42 | $1,401 | $33 |
| Escitalopram | 42 | $1,110 | $26 |
| Rosuvastatin | 67 | $1,080 | $16 |
| Albuterol Sulfate Hfa | 30 | $1,019 | $34 |
| Amlodipine Besylate | 130 | $975 | $8 |
| Lisinopril | 111 | $869 | $8 |
| Metoprolol | 46 | $865 | $19 |
| Pantoprazole | 37 | $800 | $22 |
| Valacyclovir | 11 | $726 | $66 |
| Liothyronine | 16 | $718 | $45 |
| Celecoxib | 30 | $714 | $24 |
| Simvastatin | 52 | $697 | $13 |
| Ezetimibe | 30 | $683 | $23 |
| Trazodone | 57 | $629 | $11 |
| Valsartan | 13 | $613 | $47 |
| Potassium Chloride | 20 | $555 | $28 |
| Enalapril Maleate | 14 | $537 | $38 |
| Fluoxetine | 40 | $526 | $13 |
| Montelukast | 23 | $513 | $22 |
| Hydrochlorothiazide | 86 | $501 | $6 |
| Vilazodone | 12 | $488 | $41 |
| Diclofenac | 17 | $438 | $26 |
| Tamsulosin | 36 | $388 | $11 |
| Quetiapine | 20 | $366 | $18 |
| Citalopram Hbr | 30 | $352 | $12 |
| Donepezil | 34 | $343 | $10 |
| Fluticasone Propionate | 15 | $332 | $22 |
| Allopurinol | 26 | $319 | $12 |
| Furosemide | 28 | $313 | $11 |
| Metformin Hcl Er | 19 | $308 | $16 |
| Bupropion Xl | 12 | $301 | $25 |
| Clonazepam | 16 | $283 | $18 |
| Lamotrigine | 12 | $274 | $23 |
| Zolpidem | 29 | $258 | $9 |
| Verapamil Er | 12 | $251 | $21 |
| Atenolol | 19 | $199 | $10 |
| Triamterene-Hydrochlorothiazid | 21 | $198 | $9 |
| Nitrofurantoin Mono-Macro | 16 | $195 | $12 |
| Meloxicam | 16 | $193 | $12 |
| Metformin | 16 | $180 | $11 |
| Alendronate | 13 | $167 | $13 |
| Sertraline | 32 | $164 | $5 |
| Clopidogrel | 24 | $156 | $7 |
| Metoprolol | 17 | $139 | $8 |
| Paroxetine | 14 | $139 | $10 |
| Pravastatin | 12 | $139 | $12 |
| Azelastine | 11 | $122 | $11 |
| Ciprofloxacin | 12 | $113 | $9 |
| Azithromycin | 14 | $91 | $7 |
| Carvedilol | 11 | $88 | $8 |
| Lisinopril-Hydrochlorothiazide | 15 | $32 | $2 |
| Lorazepam | 16 | $28 | $2 |
| Paxlovid | 20 | $0 | $0 |
Year by year
| 2024 | 2,769 | 308 | 1% (21) | 8% | $178,486 |
| 2023 | 3,058 | 331 | 1% (20) | 10% | $245,969 |
| 2022 | 2,462 | 294 | 1% (27) | 8% | $161,838 |
| 2021 | 1,990 | 256 | 2% (37) | 10% | $125,120 |
| 2020 | 2,146 | 227 | 2% (45) | None | $134,485 |
| 2019 | 2,242 | 239 | 3% (62) | 13% | $141,346 |
| 2018 | 2,124 | 200 | 2% (52) | None | $142,019 |
| 2017 | 1,884 | 196 | 2% (31) | 14% | $111,518 |
| 2016 | 1,796 | 195 | 1% (24) | 16% | $108,491 |
| 2015 | 1,601 | 196 | 2% (33) | None | $100,116 |
| 2014 | 1,564 | 168 | 3% (46) | None | $88,971 |
| 2013 | 1,420 | 130 | 4% (50) | None | $76,854 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 71 drugs
| Eliquis | 37 | $39,456 | $1,066 |
| Myrbetriq | 22 | $13,113 | $596 |
| Advair Diskus | 13 | $5,701 | $439 |
| Estring | 12 | $5,676 | $473 |
| Flovent Hfa | 14 | $4,684 | $335 |
| Atorvastatin | 256 | $2,663 | $10 |
| Levothyroxine | 156 | $2,599 | $17 |
| Escitalopram | 44 | $2,265 | $51 |
| Colchicine | 12 | $2,263 | $189 |
| Quetiapine | 30 | $2,194 | $73 |
| Ezetimibe | 24 | $2,062 | $86 |
| Estradiol | 23 | $1,954 | $85 |
| Celecoxib | 29 | $1,849 | $64 |
| Losartan | 100 | $1,817 | $18 |
| Mirtazapine | 38 | $1,737 | $46 |
| Synthroid | 14 | $1,724 | $123 |
| Gabapentin | 71 | $1,544 | $22 |
| Valacyclovir | 21 | $1,496 | $71 |
| Albuterol Sulfate Hfa | 39 | $1,477 | $38 |
| Lisinopril | 117 | $1,311 | $11 |
| Omeprazole | 39 | $1,275 | $33 |
| Trazodone | 64 | $1,158 | $18 |
| Rosuvastatin | 40 | $1,109 | $28 |
| Temazepam | 22 | $1,055 | $48 |
| Carbidopa-Levodopa | 13 | $945 | $73 |
| Amlodipine Besylate | 115 | $906 | $8 |
| Pantoprazole | 49 | $892 | $18 |
| Tamsulosin | 52 | $874 | $17 |
| Potassium Chloride | 15 | $849 | $57 |
| Metoprolol | 52 | $838 | $16 |
| Liothyronine | 16 | $811 | $51 |
| Amitriptyline | 23 | $781 | $34 |
| Fluoxetine | 49 | $780 | $16 |
| Donepezil | 40 | $738 | $18 |
| Montelukast | 31 | $715 | $23 |
| Fluticasone Propionate | 25 | $679 | $27 |
| Simvastatin | 60 | $617 | $10 |
| Doxycycline Hyclate | 20 | $601 | $30 |
| Valsartan | 13 | $577 | $44 |
| Hydrochlorothiazide | 89 | $547 | $6 |
| Vilazodone | 13 | $542 | $42 |
| Buspirone | 14 | $484 | $35 |
| Primidone | 12 | $483 | $40 |
| Diclofenac | 18 | $431 | $24 |
| Sertraline | 32 | $420 | $13 |
| Zolpidem | 40 | $397 | $10 |
| Paxlovid (Eua) | 37 | $381 | $10 |
| Metformin | 32 | $332 | $10 |
| Clopidogrel | 29 | $330 | $11 |
| Chlorthalidone | 11 | $297 | $27 |
| Alendronate | 23 | $276 | $12 |
| Triamterene-Hydrochlorothiazid | 23 | $268 | $12 |
| Allopurinol | 25 | $247 | $10 |
| Atenolol | 18 | $236 | $13 |
| Amoxicillin-Clavulanate Potass | 14 | $212 | $15 |
| Meloxicam | 18 | $196 | $11 |
| Hydralazine | 12 | $179 | $15 |
| Metoprolol | 23 | $170 | $7 |
| Pravastatin | 18 | $157 | $9 |
| Carvedilol | 11 | $154 | $14 |
| Citalopram Hbr | 24 | $147 | $6 |
| Finasteride | 11 | $140 | $13 |
| Hydrocodone-Acetaminophen | 12 | $139 | $12 |
| Lorazepam | 20 | $122 | $6 |
| Metformin Hcl Er | 20 | $115 | $6 |
| Furosemide | 18 | $104 | $6 |
| Lisinopril-Hydrochlorothiazide | 12 | $91 | $8 |
| Diazepam | 19 | $59 | $3 |
| Pramipexole Dihydrochloride | 11 | $56 | $5 |
| Azithromycin | 11 | $45 | $4 |
| Warfarin | 11 | $29 | $3 |
2022: 64 drugs
| Eliquis | 24 | $32,661 | $1,361 |
| Escitalopram | 52 | $7,622 | $147 |
| Myrbetriq | 16 | $7,357 | $460 |
| Colchicine | 12 | $3,592 | $299 |
| Flovent Hfa | 11 | $3,331 | $303 |
| Synthroid | 19 | $2,445 | $129 |
| Atorvastatin | 191 | $1,817 | $10 |
| Levothyroxine | 106 | $1,774 | $17 |
| Gabapentin | 56 | $1,772 | $32 |
| Mirtazapine | 38 | $1,753 | $46 |
| Losartan | 89 | $1,608 | $18 |
| Raloxifene | 15 | $1,603 | $107 |
| Memantine | 11 | $1,540 | $140 |
| Memantine Hcl Er | 11 | $1,361 | $124 |
| Quetiapine | 39 | $1,278 | $33 |
| Diclofenac | 12 | $1,131 | $94 |
| Pantoprazole | 40 | $1,079 | $27 |
| Valacyclovir | 16 | $1,037 | $65 |
| Lisinopril | 92 | $1,009 | $11 |
| Albuterol Sulfate Hfa | 20 | $990 | $50 |
| Donepezil | 63 | $981 | $16 |
| Carbidopa-Levodopa | 24 | $941 | $39 |
| Omeprazole | 26 | $890 | $34 |
| Bupropion Xl | 15 | $880 | $59 |
| Temazepam | 27 | $864 | $32 |
| Rosuvastatin | 35 | $852 | $24 |
| Estradiol | 11 | $819 | $74 |
| Celecoxib | 19 | $770 | $41 |
| Trazodone | 47 | $716 | $15 |
| Metoprolol | 39 | $677 | $17 |
| Oxybutynin Chloride Er | 11 | $584 | $53 |
| Levetiracetam | 13 | $535 | $41 |
| Amitriptyline | 14 | $518 | $37 |
| Amlodipine Besylate | 83 | $516 | $6 |
| Hydrochlorothiazide | 80 | $511 | $6 |
| Tamsulosin | 48 | $509 | $11 |
| Liothyronine | 13 | $509 | $39 |
| Fluticasone Propionate | 14 | $476 | $34 |
| Progesterone | 11 | $453 | $41 |
| Montelukast | 21 | $442 | $21 |
| Sertraline | 29 | $435 | $15 |
| Simvastatin | 62 | $422 | $7 |
| Fluoxetine | 23 | $351 | $15 |
| Pravastatin | 21 | $301 | $14 |
| Zolpidem | 33 | $265 | $8 |
| Metformin | 30 | $249 | $8 |
| Atenolol | 18 | $216 | $12 |
| Buspirone | 19 | $203 | $11 |
| Meloxicam | 19 | $197 | $10 |
| Hydrocodone-Acetaminophen | 18 | $196 | $11 |
| Allopurinol | 16 | $182 | $11 |
| Triamterene-Hydrochlorothiazid | 11 | $170 | $15 |
| Paxlovid (Eua) | 15 | $152 | $10 |
| Hydralazine | 13 | $145 | $11 |
| Finasteride | 16 | $144 | $9 |
| Alendronate | 12 | $111 | $9 |
| Lorazepam | 20 | $92 | $5 |
| Eszopiclone | 11 | $82 | $7 |
| Clopidogrel | 20 | $81 | $4 |
| Carvedilol | 13 | $61 | $5 |
| Citalopram Hbr | 23 | $61 | $3 |
| Diazepam | 16 | $56 | $4 |
| Metformin Hcl Er | 19 | $50 | $3 |
| Metoprolol | 14 | $42 | $3 |
2021: 52 drugs
| Eliquis | 12 | $14,755 | $1,230 |
| Premarin | 11 | $5,349 | $486 |
| Flovent Hfa | 15 | $4,188 | $279 |
| Viibryd | 12 | $3,762 | $313 |
| Bystolic | 14 | $2,927 | $209 |
| Escitalopram | 44 | $2,442 | $56 |
| Estradiol | 22 | $2,370 | $108 |
| Levothyroxine | 93 | $1,937 | $21 |
| Atorvastatin | 145 | $1,702 | $12 |
| Gabapentin | 47 | $1,486 | $32 |
| Diclofenac | 19 | $1,473 | $78 |
| Celecoxib | 17 | $1,421 | $84 |
| Synthroid | 11 | $1,177 | $107 |
| Rosuvastatin | 21 | $1,158 | $55 |
| Carbidopa-Levodopa | 16 | $1,045 | $65 |
| Mirtazapine | 34 | $1,033 | $30 |
| Levetiracetam | 18 | $961 | $53 |
| Montelukast | 26 | $815 | $31 |
| Lisinopril | 74 | $756 | $10 |
| Quetiapine | 26 | $706 | $27 |
| Trazodone | 50 | $661 | $13 |
| Albuterol Sulfate Hfa | 16 | $659 | $41 |
| Pantoprazole | 48 | $656 | $14 |
| Losartan | 53 | $607 | $11 |
| Metoprolol | 36 | $595 | $17 |
| Valacyclovir | 14 | $575 | $41 |
| Hydrochlorothiazide | 81 | $555 | $7 |
| Donepezil | 48 | $546 | $11 |
| Enalapril Maleate | 14 | $502 | $36 |
| Omeprazole | 18 | $447 | $25 |
| Tamsulosin | 25 | $394 | $16 |
| Sertraline | 18 | $390 | $22 |
| Fluticasone Propionate | 12 | $389 | $32 |
| Simvastatin | 48 | $372 | $8 |
| Amlodipine Besylate | 51 | $332 | $7 |
| Citalopram Hbr | 25 | $293 | $12 |
| Pravastatin | 13 | $264 | $20 |
| Zolpidem | 19 | $258 | $14 |
| Fluoxetine | 12 | $252 | $21 |
| Allopurinol | 20 | $243 | $12 |
| Finasteride | 23 | $218 | $9 |
| Liothyronine | 12 | $180 | $15 |
| Meloxicam | 18 | $176 | $10 |
| Hydrocodone-Acetaminophen | 13 | $126 | $10 |
| Metoprolol | 11 | $89 | $8 |
| Mupirocin | 13 | $82 | $6 |
| Pramipexole Dihydrochloride | 11 | $74 | $7 |
| Diazepam | 29 | $71 | $2 |
| Metformin | 22 | $70 | $3 |
| Carvedilol | 13 | $67 | $5 |
| Lorazepam | 15 | $63 | $4 |
| Furosemide | 13 | $21 | $2 |
2020: 60 drugs
| Premarin | 19 | $5,460 | $287 |
| Flovent Hfa | 18 | $5,006 | $278 |
| Colchicine | 16 | $3,870 | $242 |
| Bystolic | 17 | $3,773 | $222 |
| Oxycontin | 13 | $3,441 | $265 |
| Levothyroxine | 119 | $3,246 | $27 |
| Synthroid | 26 | $2,228 | $86 |
| Atorvastatin | 151 | $2,201 | $15 |
| Estradiol | 15 | $1,622 | $108 |
| Gabapentin | 51 | $1,611 | $32 |
| Celecoxib | 16 | $1,305 | $82 |
| Rosuvastatin | 13 | $1,211 | $93 |
| Bupropion Xl | 16 | $1,050 | $66 |
| Pantoprazole | 46 | $970 | $21 |
| Carbidopa-Levodopa | 14 | $946 | $68 |
| Diclofenac | 22 | $907 | $41 |
| Montelukast | 29 | $813 | $28 |
| Mirtazapine | 23 | $778 | $34 |
| Losartan | 55 | $766 | $14 |
| Quetiapine | 32 | $760 | $24 |
| Albuterol Sulfate Hfa | 15 | $738 | $49 |
| Metoprolol | 31 | $689 | $22 |
| Enalapril Maleate | 15 | $657 | $44 |
| Warfarin | 19 | $639 | $34 |
| Trazodone | 56 | $631 | $11 |
| Lisinopril | 84 | $624 | $7 |
| Amitriptyline | 21 | $580 | $28 |
| Simvastatin | 58 | $549 | $9 |
| Hydrochlorothiazide | 71 | $525 | $7 |
| Escitalopram | 27 | $485 | $18 |
| Finasteride | 20 | $458 | $23 |
| Levetiracetam | 11 | $452 | $41 |
| Primidone | 12 | $437 | $36 |
| Allopurinol | 29 | $432 | $15 |
| Omeprazole | 21 | $414 | $20 |
| Amlodipine Besylate | 43 | $405 | $9 |
| Citalopram Hbr | 17 | $328 | $19 |
| Donepezil | 32 | $322 | $10 |
| Triamterene-Hydrochlorothiazid | 16 | $293 | $18 |
| Duloxetine | 13 | $288 | $22 |
| Fluoxetine | 12 | $283 | $24 |
| Lisinopril-Hydrochlorothiazide | 14 | $276 | $20 |
| Clopidogrel | 12 | $271 | $23 |
| Sertraline | 14 | $253 | $18 |
| Tamsulosin | 15 | $251 | $17 |
| Pravastatin | 15 | $232 | $15 |
| Hydrocodone-Acetaminophen | 23 | $207 | $9 |
| Metformin | 28 | $199 | $7 |
| Zolpidem | 22 | $177 | $8 |
| Oxybutynin Chloride | 12 | $164 | $14 |
| Sumatriptan | 11 | $164 | $15 |
| Alendronate | 17 | $160 | $9 |
| Benazepril | 12 | $158 | $13 |
| Atenolol | 11 | $135 | $12 |
| Meloxicam | 15 | $128 | $9 |
| Azithromycin | 12 | $126 | $11 |
| Eszopiclone | 12 | $105 | $9 |
| Quinapril | 11 | $87 | $8 |
| Lorazepam | 19 | $86 | $5 |
| Furosemide | 12 | $35 | $3 |
2019: 59 drugs
| Estradiol | 36 | $5,948 | $165 |
| Premarin | 18 | $5,305 | $295 |
| Bystolic | 21 | $5,041 | $240 |
| Dexilant | 12 | $5,022 | $418 |
| Levothyroxine | 119 | $2,614 | $22 |
| Atorvastatin | 132 | $2,126 | $16 |
| Synthroid | 22 | $2,107 | $96 |
| Gabapentin | 55 | $2,062 | $37 |
| Duloxetine | 22 | $1,823 | $83 |
| Proair Hfa | 22 | $1,812 | $82 |
| Mirtazapine | 43 | $1,357 | $32 |
| Celecoxib | 17 | $1,108 | $65 |
| Bupropion Xl | 11 | $1,073 | $98 |
| Rosuvastatin | 11 | $1,044 | $95 |
| Losartan | 59 | $1,017 | $17 |
| Memantine | 15 | $800 | $53 |
| Enalapril Maleate | 16 | $766 | $48 |
| Pantoprazole | 49 | $734 | $15 |
| Lisinopril | 72 | $673 | $9 |
| Escitalopram | 33 | $669 | $20 |
| Quetiapine | 25 | $656 | $26 |
| Amlodipine Besylate | 47 | $649 | $14 |
| Hydrocodone-Acetaminophen | 29 | $631 | $22 |
| Trazodone | 45 | $612 | $14 |
| Fluoxetine | 14 | $603 | $43 |
| Simvastatin | 51 | $601 | $12 |
| Montelukast | 32 | $600 | $19 |
| Diclofenac | 15 | $592 | $39 |
| Amitriptyline | 21 | $547 | $26 |
| Hydrochlorothiazide | 63 | $515 | $8 |
| Finasteride | 15 | $503 | $34 |
| Ipratropium | 15 | $502 | $33 |
| Donepezil | 39 | $493 | $13 |
| Fluticasone Propionate | 18 | $491 | $27 |
| Allopurinol | 37 | $426 | $12 |
| Triamterene-Hydrochlorothiazid | 24 | $412 | $17 |
| Irbesartan | 11 | $398 | $36 |
| Pravastatin | 19 | $391 | $21 |
| Metoprolol | 24 | $382 | $16 |
| Sertraline | 15 | $358 | $24 |
| Tamsulosin | 16 | $341 | $21 |
| Primidone | 20 | $313 | $16 |
| Ranitidine | 14 | $311 | $22 |
| Warfarin | 12 | $306 | $26 |
| Citalopram Hbr | 16 | $293 | $18 |
| Meloxicam | 18 | $267 | $15 |
| Omeprazole | 14 | $266 | $19 |
| Clonidine | 19 | $241 | $13 |
| Zolpidem | 28 | $223 | $8 |
| Metformin | 21 | $199 | $9 |
| Clopidogrel | 14 | $192 | $14 |
| Azithromycin | 23 | $163 | $7 |
| Alendronate | 20 | $151 | $8 |
| Benazepril | 12 | $118 | $10 |
| Lorazepam | 17 | $109 | $6 |
| Furosemide | 20 | $107 | $5 |
| Metoprolol | 14 | $89 | $6 |
| Oxybutynin Chloride | 12 | $63 | $5 |
| Diazepam | 11 | $49 | $4 |
2018: 62 drugs
| Xarelto | 17 | $11,252 | $662 |
| Premarin | 12 | $4,962 | $414 |
| Dexilant | 14 | $4,222 | $302 |
| Colchicine | 13 | $3,657 | $281 |
| Estradiol | 21 | $3,278 | $156 |
| Flovent Hfa | 11 | $3,242 | $295 |
| Gabapentin | 65 | $2,627 | $40 |
| Levothyroxine | 116 | $2,599 | $22 |
| Atorvastatin | 122 | $2,371 | $19 |
| Synthroid | 27 | $2,338 | $87 |
| Celecoxib | 11 | $2,106 | $191 |
| Memantine | 24 | $1,556 | $65 |
| Bupropion Xl | 13 | $1,187 | $91 |
| Proair Hfa | 13 | $1,074 | $83 |
| Rosuvastatin | 24 | $969 | $40 |
| Mirtazapine | 41 | $895 | $22 |
| Valsartan | 15 | $873 | $58 |
| Bupropion Hcl Sr | 14 | $821 | $59 |
| Venlafaxine Hcl Er | 13 | $810 | $62 |
| Donepezil | 29 | $766 | $26 |
| Tamsulosin | 22 | $757 | $34 |
| Ipratropium | 13 | $668 | $51 |
| Lisinopril | 87 | $666 | $8 |
| Losartan | 52 | $637 | $12 |
| Simvastatin | 51 | $631 | $12 |
| Valsartan-Hydrochlorothiazide | 13 | $619 | $48 |
| Enalapril Maleate | 17 | $598 | $35 |
| Pantoprazole | 59 | $582 | $10 |
| Metoprolol | 33 | $576 | $17 |
| Montelukast | 23 | $500 | $22 |
| Digoxin | 12 | $473 | $39 |
| Quetiapine | 18 | $448 | $25 |
| Trazodone | 39 | $440 | $11 |
| Diclofenac | 15 | $430 | $29 |
| Amlodipine Besylate | 34 | $405 | $12 |
| Hydrochlorothiazide | 57 | $398 | $7 |
| Triamterene-Hydrochlorothiazid | 25 | $396 | $16 |
| Cyclobenzaprine | 15 | $381 | $25 |
| Fluticasone Propionate | 21 | $376 | $18 |
| Escitalopram | 18 | $356 | $20 |
| Amitriptyline | 20 | $353 | $18 |
| Finasteride | 11 | $344 | $31 |
| Sertraline | 17 | $307 | $18 |
| Allopurinol | 26 | $306 | $12 |
| Pravastatin | 17 | $301 | $18 |
| Hydrocodone-Acetaminophen | 26 | $299 | $12 |
| Warfarin | 13 | $294 | $23 |
| Primidone | 19 | $268 | $14 |
| Lamotrigine | 12 | $264 | $22 |
| Meloxicam | 13 | $245 | $19 |
| Metformin | 24 | $239 | $10 |
| Citalopram Hbr | 20 | $220 | $11 |
| Oxycodone-Acetaminophen | 13 | $180 | $14 |
| Azithromycin | 17 | $161 | $9 |
| Atenolol | 14 | $153 | $11 |
| Lorazepam | 17 | $148 | $9 |
| Zolpidem | 20 | $128 | $6 |
| Metoprolol | 16 | $115 | $7 |
| Acyclovir | 11 | $82 | $7 |
| Cephalexin | 12 | $71 | $6 |
| Furosemide | 16 | $69 | $4 |
| Losartan-Hydrochlorothiazide | 11 | $19 | $2 |
2017: 54 drugs
| Xarelto | 17 | $7,064 | $416 |
| Premarin | 11 | $4,312 | $392 |
| Cevimeline | 13 | $3,562 | $274 |
| Levothyroxine | 94 | $2,620 | $28 |
| Diltiazem 12hr Er | 14 | $2,193 | $157 |
| Synthroid | 27 | $1,924 | $71 |
| Valsartan | 29 | $1,748 | $60 |
| Atorvastatin | 100 | $1,714 | $17 |
| Celecoxib | 12 | $1,323 | $110 |
| Tamsulosin | 25 | $1,286 | $51 |
| Memantine | 15 | $1,035 | $69 |
| Gabapentin | 53 | $897 | $17 |
| Bupropion Hcl Sr | 25 | $851 | $34 |
| Nifedipine Er | 12 | $601 | $50 |
| Venlafaxine Hcl Er | 15 | $565 | $38 |
| Metoprolol | 23 | $546 | $24 |
| Valsartan-Hydrochlorothiazide | 15 | $543 | $36 |
| Bupropion | 13 | $511 | $39 |
| Enalapril Maleate | 12 | $505 | $42 |
| Finasteride | 26 | $466 | $18 |
| Mirtazapine | 42 | $451 | $11 |
| Pravastatin | 21 | $444 | $21 |
| Pantoprazole | 34 | $434 | $13 |
| Warfarin | 20 | $422 | $21 |
| Zolpidem | 31 | $419 | $14 |
| Simvastatin | 45 | $408 | $9 |
| Fluticasone Propionate | 17 | $401 | $24 |
| Diclofenac | 17 | $369 | $22 |
| Lisinopril | 50 | $323 | $6 |
| Trazodone | 43 | $321 | $7 |
| Donepezil | 29 | $320 | $11 |
| Montelukast | 20 | $314 | $16 |
| Amitriptyline | 15 | $303 | $20 |
| Triamterene-Hydrochlorothiazid | 24 | $291 | $12 |
| Losartan | 42 | $278 | $7 |
| Sertraline | 14 | $265 | $19 |
| Amlodipine Besylate | 37 | $265 | $7 |
| Hydrochlorothiazide | 54 | $250 | $5 |
| Omeprazole | 15 | $228 | $15 |
| Meloxicam | 24 | $218 | $9 |
| Primidone | 20 | $213 | $11 |
| Azithromycin | 28 | $169 | $6 |
| Escitalopram | 19 | $145 | $8 |
| Metformin | 26 | $144 | $6 |
| Amoxicillin-Clavulanate Potass | 13 | $138 | $11 |
| Hydrocodone-Acetaminophen | 15 | $126 | $8 |
| Famotidine | 16 | $124 | $8 |
| Citalopram Hbr | 23 | $100 | $4 |
| Ciprofloxacin | 16 | $99 | $6 |
| Furosemide | 20 | $94 | $5 |
| Acyclovir | 11 | $88 | $8 |
| Lorazepam | 13 | $88 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $61 | $5 |
| Cyclobenzaprine | 16 | $54 | $3 |
2016: 50 drugs
| Xarelto | 20 | $8,648 | $432 |
| Premarin | 12 | $4,153 | $346 |
| Flovent Hfa | 14 | $3,946 | $282 |
| Diovan | 11 | $2,703 | $246 |
| Celecoxib | 19 | $2,616 | $138 |
| Synthroid | 40 | $2,499 | $62 |
| Levothyroxine | 88 | $2,267 | $26 |
| Tolterodine Tartrate Er | 11 | $1,991 | $181 |
| Atorvastatin | 90 | $1,585 | $18 |
| Proair Hfa | 16 | $1,473 | $92 |
| Gabapentin | 55 | $1,142 | $21 |
| Estradiol | 13 | $1,120 | $86 |
| Tamsulosin | 23 | $819 | $36 |
| Valsartan | 19 | $718 | $38 |
| Escitalopram | 20 | $578 | $29 |
| Losartan | 54 | $562 | $10 |
| Pantoprazole | 41 | $551 | $13 |
| Bupropion Hcl Sr | 27 | $548 | $20 |
| Montelukast | 16 | $529 | $33 |
| Zolpidem | 40 | $509 | $13 |
| Omeprazole | 21 | $465 | $22 |
| Rabeprazole | 12 | $402 | $33 |
| Simvastatin | 49 | $399 | $8 |
| Pravastatin | 21 | $398 | $19 |
| Metoprolol | 14 | $393 | $28 |
| Trazodone | 36 | $393 | $11 |
| Lisinopril | 60 | $387 | $6 |
| Enalapril Maleate | 17 | $386 | $23 |
| Fluticasone Propionate | 16 | $317 | $20 |
| Finasteride | 26 | $291 | $11 |
| Azithromycin | 35 | $280 | $8 |
| Hydrochlorothiazide | 49 | $279 | $6 |
| Bupropion | 12 | $253 | $21 |
| Diclofenac | 14 | $250 | $18 |
| Sertraline | 20 | $212 | $11 |
| Triamterene-Hydrochlorothiazid | 17 | $207 | $12 |
| Warfarin | 15 | $191 | $13 |
| Lorazepam | 17 | $162 | $10 |
| Meloxicam | 31 | $160 | $5 |
| Donepezil | 19 | $159 | $8 |
| Metformin | 31 | $157 | $5 |
| Amlodipine Besylate | 29 | $156 | $5 |
| Mirtazapine | 18 | $153 | $8 |
| Primidone | 12 | $148 | $12 |
| Citalopram Hbr | 15 | $123 | $8 |
| Atenolol | 13 | $112 | $9 |
| Ciprofloxacin | 17 | $97 | $6 |
| Acyclovir | 11 | $89 | $8 |
| Furosemide | 22 | $80 | $4 |
| Clonidine | 11 | $72 | $7 |
2015: 49 drugs
| Nexium | 11 | $9,913 | $901 |
| Celecoxib | 27 | $5,020 | $186 |
| Bystolic | 17 | $4,521 | $266 |
| Premarin | 12 | $4,223 | $352 |
| Diovan | 14 | $2,669 | $191 |
| Valsartan | 22 | $2,188 | $99 |
| Tolterodine Tartrate Er | 11 | $1,983 | $180 |
| Synthroid | 44 | $1,936 | $44 |
| Levothyroxine | 56 | $1,595 | $28 |
| Potassium Chloride | 15 | $1,304 | $87 |
| Atorvastatin | 62 | $1,120 | $18 |
| Zafirlukast | 13 | $862 | $66 |
| Pantoprazole | 42 | $832 | $20 |
| Tamsulosin | 17 | $823 | $48 |
| Gabapentin | 51 | $694 | $14 |
| Simvastatin | 47 | $590 | $13 |
| Valsartan-Hydrochlorothiazide | 11 | $552 | $50 |
| Bupropion Hcl Sr | 25 | $537 | $21 |
| Pravastatin | 18 | $511 | $28 |
| Enalapril Maleate | 17 | $447 | $26 |
| Zolpidem | 35 | $441 | $13 |
| Finasteride | 24 | $424 | $18 |
| Lisinopril | 58 | $386 | $7 |
| Bupropion | 12 | $380 | $32 |
| Triamterene-Hydrochlorothiazid | 17 | $379 | $22 |
| Diltiazem 24hr Cd | 12 | $377 | $31 |
| Hydrochlorothiazide | 54 | $343 | $6 |
| Losartan | 25 | $341 | $14 |
| Fluticasone Propionate | 12 | $319 | $27 |
| Trazodone | 21 | $286 | $14 |
| Amlodipine Besylate | 40 | $257 | $6 |
| Amoxicillin-Clavulanate Potass | 13 | $178 | $14 |
| Omeprazole | 12 | $176 | $15 |
| Paroxetine | 19 | $172 | $9 |
| Metformin | 30 | $141 | $5 |
| Benazepril | 14 | $129 | $9 |
| Escitalopram | 17 | $127 | $7 |
| Donepezil | 24 | $124 | $5 |
| Lorazepam | 15 | $122 | $8 |
| Furosemide | 30 | $120 | $4 |
| Azithromycin | 18 | $117 | $7 |
| Pentoxifylline | 12 | $105 | $9 |
| Meloxicam | 25 | $101 | $4 |
| Acyclovir | 12 | $95 | $8 |
| Glipizide | 14 | $83 | $6 |
| Citalopram Hbr | 14 | $82 | $6 |
| Metoprolol | 15 | $79 | $5 |
| Fluoxetine | 14 | $68 | $5 |
| Ciprofloxacin | 12 | $64 | $5 |
2014: 36 drugs
| Diovan | 34 | $6,692 | $197 |
| Celebrex | 21 | $5,646 | $269 |
| Bystolic | 11 | $2,328 | $212 |
| Proair Hfa | 20 | $2,208 | $110 |
| Trospium Chloride Er | 11 | $1,838 | $167 |
| Levothyroxine | 88 | $1,741 | $20 |
| Atorvastatin | 57 | $1,396 | $24 |
| Synthroid | 32 | $1,229 | $38 |
| Gabapentin | 52 | $936 | $18 |
| Tolterodine | 11 | $934 | $85 |
| Metoprolol | 20 | $723 | $36 |
| Valsartan-Hydrochlorothiazide | 12 | $716 | $60 |
| Hydrochlorothiazide | 90 | $606 | $7 |
| Fluticasone Propionate | 18 | $575 | $32 |
| Amlodipine Besylate | 68 | $563 | $8 |
| Pantoprazole | 42 | $561 | $13 |
| Simvastatin | 48 | $531 | $11 |
| Lisinopril | 58 | $491 | $8 |
| Pravastatin | 21 | $467 | $22 |
| Hydrocodone-Acetaminophen | 12 | $304 | $25 |
| Trazodone | 28 | $284 | $10 |
| Losartan | 26 | $280 | $11 |
| Zolpidem | 35 | $246 | $7 |
| Donepezil | 17 | $202 | $12 |
| Metformin | 26 | $192 | $7 |
| Meloxicam | 38 | $182 | $5 |
| Citalopram Hbr | 25 | $176 | $7 |
| Lorazepam | 20 | $136 | $7 |
| Azithromycin | 17 | $119 | $7 |
| Furosemide | 30 | $116 | $4 |
| Metoprolol | 17 | $114 | $7 |
| Escitalopram | 14 | $107 | $8 |
| Temazepam | 11 | $103 | $9 |
| Atenolol | 11 | $80 | $7 |
| Ciprofloxacin | 12 | $71 | $6 |
| Alprazolam | 20 | $68 | $3 |
2013: 36 drugs
| Diovan | 40 | $7,630 | $191 |
| Celebrex | 16 | $4,682 | $293 |
| Valsartan-Hydrochlorothiazide | 18 | $2,050 | $114 |
| Proair Hfa | 34 | $1,864 | $55 |
| Oxycontin | 13 | $1,714 | $132 |
| Benicar | 13 | $1,369 | $105 |
| Atorvastatin | 43 | $1,312 | $31 |
| Levothyroxine | 85 | $1,152 | $14 |
| Pantoprazole | 37 | $1,094 | $30 |
| Tolterodine | 11 | $950 | $86 |
| Amlodipine Besylate | 67 | $879 | $13 |
| Synthroid | 28 | $847 | $30 |
| Hydrochlorothiazide | 78 | $598 | $8 |
| Fluticasone Propionate | 20 | $507 | $25 |
| Gabapentin | 22 | $502 | $23 |
| Lisinopril | 63 | $499 | $8 |
| Atenolol | 17 | $496 | $29 |
| Simvastatin | 41 | $477 | $12 |
| Metoprolol | 15 | $464 | $31 |
| Losartan | 30 | $446 | $15 |
| Diltiazem 24hr Cd | 14 | $427 | $31 |
| Escitalopram | 19 | $401 | $21 |
| Meloxicam | 54 | $391 | $7 |
| Metformin | 33 | $313 | $9 |
| Zolpidem | 37 | $272 | $7 |
| Pravastatin | 14 | $239 | $17 |
| Paroxetine | 16 | $231 | $14 |
| Donepezil | 17 | $216 | $13 |
| Hydrocodone-Acetaminophen | 18 | $209 | $12 |
| Lorazepam | 28 | $186 | $7 |
| Metoprolol | 19 | $183 | $10 |
| Temazepam | 12 | $164 | $14 |
| Azithromycin | 15 | $120 | $8 |
| Furosemide | 21 | $118 | $6 |
| Citalopram Hbr | 17 | $95 | $6 |
| Ciprofloxacin | 16 | $65 | $4 |
Money from drug and device companies
$256 in 2025
| 2025 | 6 | 11 | None | $256 |
| 2024 | 3 | 5 | None | $114 |
| 2023 | 4 | 6 | None | $141 |
| 2022 | 3 | 3 | None | $85 |
| 2021 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $93 | 4 payments
|
| Novo Nordisk | Ozempic | $54 | 2 payments
|
| Pfizer | Prevnar 20 | $39 | 2 payments
|
| Axsome Therapeutics | Sunosi | $32 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $22 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | Rexulti | $16 | 1 payment
|
See all 11 published payments
| Pfizer | Meals · 2025-12-11 | Prevnar 20 | $21 |
| Astellas Pharma US | Meals · 2025-12-05 | Veozah | $22 |
| Pfizer | Meals · 2025-09-20 | Prevnar 20 | $18 |
| Astellas Pharma US | Meals · 2025-08-27 | Veozah | $24 |
| Novo Nordisk | Meals · 2025-07-11 | None | $31 |
| Astellas Pharma US | Meals · 2025-07-11 | Veozah | $22 |
| Axsome Therapeutics | Meals · 2025-06-28 | Sunosi | $32 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-06-20 | Rexulti | $16 |
| Astellas Pharma US | Meals · 2025-04-18 | Veozah | $24 |
| Exact Sciences | Meals · 2025-03-08 | Cologuard Collection Kit | $22 |
| Novo Nordisk | Meals · 2025-01-17 | Ozempic | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $114
| Exact Sciences | Cologuard Collection Kit | $73 | 3 payments
|
| Amgen | Repatha | $23 | 1 payment
|
| Pfizer | Myfembree | $17 | 1 payment
|
2023: $141
| AstraZeneca Pharmaceuticals LP | Farxiga | $45 | 2 payments
|
| Lilly USA | Mounjaro | $44 | 2 payments
|
| Pfizer | Premarin | $27 | 1 payment
|
| Kyowa Kirin | Crysvita | $25 | 1 payment
|
2022: $85
| Pfizer | Prevnar 20 | $33 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $30 | 1 payment
|
| GlaxoSmithKline | Shingrix | $22 | 1 payment
|
2021: $20
| Lilly USA | Emgality | $20 | 1 payment
|
Professional record
- NPI
- 1356491724
- Licence
- CA A71432, TX H2254California A71432: Current · expires 2027-10-31
- Trained
- University of Texas Medical School at Houston, 1986 · 40 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 3000 Colby St, Suite 200, Berkeley, CA, 94705
- NPI first listed
- 2007-01-10
- NPI last updated
- 2014-04-14
This is when the NPI record was last certified, not a medical board exam.